Andrew Hirsch

Andrew Hirsch is a declared insider at 2 companies (chief executive); the most frequent names are C4 Therapeutics, Inc. and Agios Pharmaceuticals, Inc. In total, 34 filings cover trades dated from 20 January 2019 to 15 February 2026.

Purchases make up the whole of the open-market record (1 purchase, €78k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 20 share grants and 13 option exercises.

The latest filing, published on 18 February 2026, reports an option exercise in C4 Therapeutics, Inc. The latest purchase dates back some time: it was published 1,656 days ago, on 12 April 2022. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.